KRSA · Korsana Biosciences, Inc. · Proposed Sales
$31.65
+0.37 (+1.18%)
At close · Nov 13
Return incl. dividend (before tax)
Going-concern doubt
— cleared Nov 5, 2026
The latest filing no longer states the doubt (first flagged Aug 4, 2026).
View the 10-Q filed Nov 5, 2026Market Cap
$1.44B
Shares
45.54M
Volume · Nov 13
225.52K
Avg daily vol (48 sessions)
127.06K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-10-22 | MICHAEL HIGGINS | Director | 1,107 | 2026-10-22 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-23 | ERROL B DE SOUZA | Director | 4,903 | 2026-09-23 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-22 | ERROL B DE SOUZA | Director | 100 | 2026-09-22 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-18 | ERROL B DE SOUZA | Director | 2,139 | 2026-09-18 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–4 of 4 filings
Key facts
CIK
1755237
CUSIP
23255M303
13F (30d)
36 filings
23 filers
Visit website
Investor relations